Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas
Jiayi Zeng, Xiangxue Li, Max Sander, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Glioblastoma Treatment: State-of-the-Art and Future Perspectives
Alejandro Rodríguez-Camacho, José Guillermo Flores-Vázquez, Júlia Moscardini-Martelli, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7207-7207
Open Access | Times Cited: 77
Teserpaturev/G47Δ: First Approval
James E. Frampton
BioDrugs (2022) Vol. 36, Iss. 5, pp. 667-672
Closed Access | Times Cited: 51
Oncolytic viruses: challenges and considerations in an evolving clinical landscape
Ulrich M. Lauer, Julia Beil
Future Oncology (2022) Vol. 18, Iss. 24, pp. 2713-2732
Open Access | Times Cited: 45
Multiple therapeutic approaches of glioblastoma multiforme: From terminal to therapy
Smita Kumari, Rohan Gupta, Rashmi K. Ambasta, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 4, pp. 188913-188913
Closed Access | Times Cited: 24
Therapeutic bacteria and viruses to combat cancer: double-edged sword in cancer therapy: new insights for future
Aref Yarahmadi, M. Amin Zare, Masoomeh Aghayari, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Enhancing cancer therapy: the integration of oncolytic virus therapy with diverse treatments
Yan Zhuo, Zhengbo Zhang, Yanan Chen, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Agent-based computational modeling of glioblastoma predicts that stromal density is central to oncolytic virus efficacy
Adrianne L. Jenner, Munisha Smalley, David Goldman, et al.
iScience (2022) Vol. 25, Iss. 6, pp. 104395-104395
Open Access | Times Cited: 35
Emerging trends and research foci of oncolytic virotherapy for central nervous system tumors: A bibliometric study
Kunming Cheng, Huan Zhang, Qiang Guo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28
Recurrent Glioblastoma: Ongoing Clinical Challenges and Future Prospects
Estela Pineda, Marta Domènech, Ainhoa Hernández, et al.
OncoTargets and Therapy (2023) Vol. Volume 16, pp. 71-86
Open Access | Times Cited: 18
The Dilemma of HSV-1 Oncolytic Virus Delivery: The Method Choice and Hurdles
Guijin Tang, Dawei Wang, Xiangqian Zhao, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3681-3681
Open Access | Times Cited: 18
Development and application of oncolytic viruses as the nemesis of tumor cells
Xiao Zhu, Chenyang Fan, Zhuolong Xiong, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 18
Oncolytic adenoviruses expressing checkpoint inhibitors for cancer therapy
Daoyuan Xie, Yaomei Tian, Die Hu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 16
Interactions Between Anti-Angiogenic Therapy and Immunotherapy in Glioblastoma
Saket Jain, Eric Chalif, Manish K. Aghi
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 24
Oncolytic Viruses and Cancer Immunotherapy
Jyoti Malhotra, Edward S. Kim
Current Oncology Reports (2022) Vol. 25, Iss. 1, pp. 19-28
Open Access | Times Cited: 23
Mechanisms of Cancer Resistance to Various Therapies
Asiya Batool, Waseem Rashid, Kaneez Fatima, et al.
(2024), pp. 31-75
Closed Access | Times Cited: 4
Comprehensive review on glioblastoma: nanotechnology, immunotherapy and combined therapeutic approaches
Ashish Dhiman, ya N A Shah, Dhwani Rana, et al.
RSC Pharmaceutics (2025)
Open Access
Role of AI and digital pathology for colorectal immuno-oncology
Mohsin Bilal, Mohammed Nimir, David Snead, et al.
British Journal of Cancer (2022) Vol. 128, Iss. 1, pp. 3-11
Open Access | Times Cited: 20
Microbiota in cancer: molecular mechanisms and therapeutic interventions
Zhou Chen, Defeng Guan, Zhengfeng Wang, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 12
Efficacy and adverse reaction management of oncolytic viral intervention combined with chemotherapy in patients with liver metastasis of gastrointestinal malignancy
Jie Zhang, Qianyun He, Dongliang Mao, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
Biomaterials for enhanced immunotherapy
Nicholas Cunningham, Réjean Lapointe, Sophie Lerouge
APL Bioengineering (2022) Vol. 6, Iss. 4
Open Access | Times Cited: 18
Immunotherapeutic Agents for Intratumoral Immunotherapy
Chih‐Rong Shyr, L Liu, Hui-Shan Chien, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1717-1717
Open Access | Times Cited: 10
Next Steps for Immunotherapy in Glioblastoma
Toni Cao, Derek A. Wainwright, Catalina Lee-Chang, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 4023-4023
Open Access | Times Cited: 13
Erythrocyte‐Leveraged Oncolytic Virotherapy (ELeOVt): Oncolytic Virus Assembly on Erythrocyte Surface to Combat Pulmonary Metastasis and Alleviate Side Effects
Mingyang Liu, Ruizhe Zhang, Hanwei Huang, et al.
Advanced Science (2023) Vol. 11, Iss. 5
Open Access | Times Cited: 7
Combination of Oncolytic Virotherapy with Different Antitumor Approaches against Glioblastoma
Alisa B. Ageenko, Natalia S. Vasileva, Vladimir A. Richter, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2042-2042
Open Access | Times Cited: 2
Comprehensive assessment on the applications of oncolytic viruses for cancer immunotherapy
Richard Kolade Omole, Oluwaseyi Oluwatola, Millicent Tambari Akere, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top